• Philippe KestelynEmail author
Living reference work entry


Cryptococcus is an infective fungal disease presenting in immunocompromised individuals, especially those with human immunodeficiency virus (HIV) infection. While the most common manifestation of the disease is papilledema due to involvement of the central nervous system, it can occasionally result in intraocular spread causing vitritis and endophthalmitis. One-third to one-half of patients with cryptococcal meningitis exhibit neuro-ophthalmic manifestations and vision loss is common. As the ophthalmologist might be the first physician to see these patients, he/she should be familiar with this entity. Prompt diagnosis and referral for effective therapy is mandatory. Despite progress in the rolling out antiretroviral therapy, cryptococcal meningitis is still a leading killer of AIDS patients worldwide. In the index chapter, ocular manifestations of Cryptococcus infection have been highlighted.

Suggested Reading

  1. Abassi M, Boulware DR, Rhein J. Cryptococcal meningitis: diagnosis and management update. Curr Trop Med Rep. 2015;2:90–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Avendaño J, Tanishima T, Kuwabara T. Ocular cryptococcosis. Am J Ophthalmol. 1978;86:110–3.CrossRefPubMedGoogle Scholar
  3. Baillif S, Delas J, Asrargis A, Gastaud P. Multimodal imaging of cryptococcal choroiditis – photo essay. Retina. 2013;33:249–51.CrossRefPubMedGoogle Scholar
  4. Beardsley J, Wolbers M, Kibengo FM, The CryptoDex Investigators, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med. 2016;374:542–54.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Boulware DR, Meya DB, Muzoora C, The COAT Trial Team, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370:2487–98.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Carney MD, Combs JL, Waschler W. Cryptococcal choroiditis. Retina. 1990;10:27–32.CrossRefPubMedGoogle Scholar
  7. Charles NC, Boxrud CA, Small EA. Cryptococcosis of the anterior segment in AIDS. Ophthalmology. 1992;99:813–6.CrossRefPubMedGoogle Scholar
  8. Chau TTH, Mai NH, Phu NH, et al. A prospective descsriptive study of cryptococcal meningitis in HIV uninfected patient in Vietnam – high prevalence of Cryptococcus neoformans var grubii in the absence of underlying diseae. BMC Infect Dis. 2010;10:199.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Coccia L, Calista D, Boschini A. Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with AIDS. Arch Ophthalmol. 1999;117:271–2.PubMedGoogle Scholar
  10. Ehrhorn J, Groose G, Staib F, Wollensak J. Intraocular cryptococcosis. Klin Monatsbl Augenheilkd. 1976;168:577–83. [in German].PubMedGoogle Scholar
  11. Fine HF, Chang MA, Dunn Jr JP. Bilateral cryptococcal choroidtis. Arch Ophthalmol. 2004;122:1726–7.CrossRefPubMedGoogle Scholar
  12. François J, Elewaut-Rysselaere M, De Vos E. Les mycoses oculaires. Paris: Masson & Cie; 1968. p. 266–74.Google Scholar
  13. Gandhi SA, McMeecking AA, Friedberg D, Holzman RS. Cryptococcal choroiditis in a patient with AIDS: case report and review. Clin Infect Dis. 1996;23:1193–4.CrossRefPubMedGoogle Scholar
  14. Hiles DA, Font RL. Bilateral intraocular cryptococcosis with unilateral spontaneous regression. Am J Ophthalmol. 1968;65:98–108.CrossRefPubMedGoogle Scholar
  15. Kaplan J, Vallabhaneni S, Smith R, et al. Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature. J Acquir Immune Defic Syndr. 2015;68:S331–9.CrossRefPubMedGoogle Scholar
  16. Kestelyn P, Taelman H, Bogaerts J, et al. Ophthalmic manifestations of infections with Cryptococcus neoformans in patients with the acquired immune deficiency syndrome. Am J Ophthalmol. 1993;116:721–7.CrossRefPubMedGoogle Scholar
  17. Khurana RN, Javaheri M, Rao N. Ophthalmic manifestations of immune reconstitution inflammatory syndrome associated with Cryptococcus neoformans. Ocul Immunol Inflamm. 2008;16:185–90.CrossRefPubMedGoogle Scholar
  18. Kresch ZA, Espinosa-Heidmann D, Harper T, Jamie-Miller G. Disseminated Cryptococcus with ocular cryptococcoma in a HIV-negative patient. Int Ophthalmol. 2012;32:281–4.CrossRefPubMedGoogle Scholar
  19. Loyse A, Moodley A, Rich P, et al. Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis. J Infect. 2015;70:668–75.CrossRefPubMedGoogle Scholar
  20. Mao F, Sun H, Li D. Ophthalmic manifestation in AIDS patients with cryptococcal meningitis. Zhonghua Yan Ke Za Zhi. 2015;51:364–8. [Article in Chinese].PubMedGoogle Scholar
  21. Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin N Am. 2016;30:179–206.CrossRefGoogle Scholar
  22. Meya DB, Manabe YC, Boulware DR, Janoff EN. The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum. Curr Opin Infect Dis. 2016;29:10–22.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Morinelli EN, Dugel PU, Riffenberg R, Rao NA. Infectious multifocal choroiditis in patients with AIDS. Ophthalmology. 1993;100:1014–24.CrossRefPubMedGoogle Scholar
  24. Muccioli C, Belfort Jr R, Neves R, Rao N. Limbal and choroidal Cryptococcus infection in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1995;120:539–40.CrossRefPubMedGoogle Scholar
  25. Pappas PG. An expanded role for therapeutic lumbar punctures in newly diagnosed AIDS-associated cryptococcal meningitis? Clin Infect Dis. 2014;59:1615–7.CrossRefPubMedGoogle Scholar
  26. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Disease Society of America. Clin Infect Dis. 2010;50:291–322.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Pettit TH, Edwards JE, Purdy EP, Bullock JD. Endogenous fungal endophthalmitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection & immunity. St. Louis: Mosby; 1996. p. 1262–86. Google Scholar
  28. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennet JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine. 1993;72:209–24.CrossRefGoogle Scholar
  29. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA. Visual loss in immunocompetent patients with Cryptococcus neoformans var. Trans R Soc Trop Med Hyg. 1997;91:44–9.CrossRefPubMedGoogle Scholar
  30. Sheu SJ, ChenYC KNW, Waang JH, Chen CJ. Endogenous cryptococcal endophthalmitis. Ophthalmology. 1998;105:377–81.CrossRefPubMedGoogle Scholar
  31. Shields JA, Wright DM, Augsburger JJ, Wolkowicz MI. Cryptococcal chorioretinitis. Am J Ophthalmol. 1980;89:210–7.CrossRefPubMedGoogle Scholar
  32. Shulman J, de la Cruz EL, Latkany P, Milman T, Iacob C, Sanjana V. Cryptococcal chorioretinitis with immune reconstitution inflammatory syndrome. Ocul Immunol Inflamm. 2009;17(5):314.CrossRefPubMedGoogle Scholar
  33. Tenforde MW, Wake R, Leeme T, Jarvis JN. HIV-associated cryptococcal meningitis: bridging the gap between developed and resource-limited settings. Curr Clin Microbiol Rep. 2016;3:92–102.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Waddell KM, Lucas SB, Downing RG. Case reports and small case series: conjunctival cryptococcosis in the acquired immunodeficiency syndrome. Arch Ophthalmol. 2000;118:1452–3.PubMedGoogle Scholar
  35. Weinstein JM. Fungi and mycotic disease. In: Miller NR, Newman NJ, editors. Walsh and Hoyt’s clinical neuro-ophthalmology. 6th ed. Philadelphia: Lippicott, Williams & Wilkins; 2005. p. 2817–52.Google Scholar
  36. World Health Organization. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva: World Health Organization; 2011.Google Scholar
  37. Wykoff C, Albini TA, Couvillion SS, Dubovy SR, Davis JL. Intraocular cryptococcoma. Arch Ophthalmol. 2009;127:700–2.CrossRefPubMedGoogle Scholar

Copyright information

© Springer (India) Pvt. Ltd. 2018

Authors and Affiliations

  1. 1.Department of OphthalmologyGhent University HospitalGhentBelgium

Personalised recommendations